INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Option exerciseVerified dataRule 10b5-1 plan

Gibson James R II reported PACB

See Remarks · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. — Stock Option (right to buy)

Side
M
Value
—
Shares
500.0K
Price
—
Executed
Oct 6, 2026
Disclosed
Oct 8, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 6 executedOct 8, 2026 disclosed

PACB · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
11/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 50.0% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · PACB

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    GR
    Gibson James R IISee Remarks
    PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    Option exercise · 10b5-1 plan
    		M$590K
    500.0K sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    22
    GR
    Gibson James R IISee Remarks
    PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    Open-market sale · 10b5-1 plan
    		SELL$2.06M
    661.8K sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    21
    GC
    Gibson ChristopherDirector
    PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    Grant or award
    		A—
    57.5K sh
    		Apr 8, 2026Apr 10, 2026
    traded Apr 8, 2026
    		+2dSEC FORM 4

    Evidence

    9
    GC
    Gibson ChristopherDirector
    PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    Grant or award
    		A—
    77.8K sh
    		Apr 8, 2026Apr 10, 2026
    traded Apr 8, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001384133-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 6, 2026
    Published
    Oct 8, 2026
    Ingested by INSIDER
    Nov 5, 02:12 UTC
    Last re-read
    Nov 5, 02:12 UTC

    Extracted facts

    Filer
    Gibson James R II
    Role
    See Remarks
    Transaction
    Option exerciseAs filed: “M”
    Asset
    PACIFIC BIOSCIENCES OF CALIFORNIA, INC. — Stock Option (right to buy)
    Ticker
    PACB
    Shares
    500.0K
    Price per share
    $0
    Execution date (reported)
    Oct 6, 2026
    Owned after transaction
    1.50M shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    2

    What this establishes

    Gibson James R II filed this Form 4 reporting a option exercise of PACB on Oct 6, 2026. It became public on Oct 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    See Remarks
    Gibson James R IIcik:0001384133
    Issuer
    PACIFIC BIOSCIENCES OF CALIFORNIA, INC.cik:0001299130

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.